Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

Wu Jiang

Status: Completed

Conditions: Hepatitis B

Study type: Observational

Funder types: Other

Identifiers

NCT04264312

BJCDCWJ202001

Details and patient eligibility

About

Through two-stage stratified cluster sampling, investigators studied the antiviral treatment rate and the main factors affecting the antiviral treatment in community chronic HBV infection-related liver disease population.

Full description

Hepatitis B virus (HBV) infection is a major public health problem worldwide. China has the world's largest burden of HBV infection and will be a major contributor towards the global elimination of hepatitis B disease by 2030. While, the antiviral treatment rate and the main factors affecting the antiviral treatment in community chronic HBV infections is still unknown. In response to the above situation, Sampling applied a two-stage stratified cluster sampling design in 16 Districts and 331 Townships. Investigators wanted to know the one who is eligible for treated criteria based on community in 25 and over years old in Beijing.

Enrollment: 76,220 patients

Sex: All

Ages: 25+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• older than 25 years old;
• Residents with medical insurance coverage lived in Beijing more than 6 months .

Exclusion criteria

• Persons with pacemakers;
• Pregnant women;
• Persons with ascites;
• The one whose wound was not cured at the right upper abdomen